What's Driving the Market Sentiment Around Dow? - Dow ( NYSE:DOW )
Dow's DOW short percent of float has risen 13.49% since its last report. The company recently reported that it has 29.38 million shares sold short, which is 4.71% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.1 days to cover their short ...
A Look Into Biomarin Pharmaceutical Inc's Price Over Earnings - Biomarin Pharmaceutical ( NASDAQ:BMRN )
Looking into the current session, Biomarin Pharmaceutical Inc. BMRN shares are trading at $64.59, after a 3.00% increase. Moreover, over the past month, the stock spiked by 3.79%, but in the past year, decreased by 23.82%.
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
TORONTO, May 02, 2025 ( GLOBE NEWSWIRE ) -- Mulvihill Enhanced Split Preferred Share ETF has declared a monthly cash distribution in the amount of $0.08333 per unit, payable on June 6, 2025 to unitholders of record on May 30, 2025.
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 ) - NewAmsterdam Pharma Co ( NASDAQ:NAMSW ) , NewAmsterdam Pharma Co ( NASDAQ:NAMS )
NAARDEN, the Netherlands and MIAMI, May 02, 2025 ( GLOBE NEWSWIRE ) -- NewAmsterdam Pharma Company N.V.
Beyond Osteo Under Review: Empower Health Labs Spartan Trick for Bone Health Support Against Osteoporosis
Why bone health quietly deteriorates with age and how it impacts long-term mobility The key signs and symptoms of osteoporosis that most people overlook How Empower Health Labs formulated the Beyond Osteo supplement using evidence-based ingredients
Greenlight Capital Re, Ltd. Schedules First Quarter 2025 Financial Results and Conference Call - Greenlight Capital Re ( NASDAQ:GLRE )
GRAND CAYMAN, Cayman Islands, May 02, 2025 ( GLOBE NEWSWIRE ) -- Greenlight Capital Re, Ltd. GLRE ( the "Company" or "Greenlight Re" ) , a multiline property and casualty insurer and reinsurer, today announced that it expects to release financial results for the first quarter ended March 31, ...
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635 ( c ) ( 4 )
BOSTON , May 02, 2025 ( GLOBE NEWSWIRE ) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on April 30, 2025, the company granted equity awards to seven new employees, pursuant to the company's 2024 ...
NurExone Expands European Engagement with Investor Events in Germany and Switzerland
TORONTO and HAIFA, Israel, May 02, 2025 ( GLOBE NEWSWIRE ) -- NurExone Biologic Inc. ( TSXV: NRX ) ( OTCQB: NRXBF ) ( FSE: J90 ) ( "NurExone" or the "Company" ) , a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system injuries, is deepening its ...
Greenlight Capital Re, Ltd. Schedules First Quarter 2025 Financial Results and Conference Call
GRAND CAYMAN, Cayman Islands, May 02, 2025 ( GLOBE NEWSWIRE ) -- Greenlight Capital Re, Ltd. ( NASDAQ: GLRE ) ( the "Company" or "Greenlight Re" ) , a multiline property and casualty insurer and reinsurer, today announced that it expects to release financial results for the first quarter ended ...
Decoding Vertiv Holdings's Options Activity: What's the Big Picture? - Vertiv Holdings ( NYSE:VRT )
Deep-pocketed investors have adopted a bullish approach towards Vertiv Holdings VRT, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.





